This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Novomics Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of Sung Hoon Noh
Introduction
Sung Hoon Noh is a notable inventor based in South Korea. He has made significant contributions to the field of medical technology, particularly in cancer treatment. His work focuses on improving the prognosis and treatment options for patients suffering from gastric cancer.
Latest Patents
Sung Hoon Noh holds a patent titled "System For Predicting Prognosis And Benefit From Adjuvant Chemotherapy For Patients With Stage II And III Gastric Cancer." This invention relates to a system that predicts prognosis and the benefits of adjuvant chemotherapy for patients with advanced gastric cancer. The algorithm developed can analyze mRNA expression levels of specific gene groups to provide supplementary information for treatment decisions.
Career Highlights
Sung Hoon Noh is associated with Novomics Co., Ltd., where he continues to innovate in the medical field. His work is crucial in enhancing the understanding of chemotherapy responsiveness in gastric cancer patients.
Collaborations
He collaborates with esteemed colleagues such as Jae Ho Cheong and Yong Min Huh, contributing to advancements in cancer research and treatment methodologies.
Conclusion
Sung Hoon Noh's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving patient outcomes. His work is a testament to the importance of research and innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile